World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
125
Citations
75807
World Ranking
3034
National Ranking
1673

Naga Chalasani publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Naga Chalasani sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 813 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Naga Chalasani D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Naga Chalasani sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 125 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Naga Chalasani is affiliated with Indiana University in the United States and specializes in medicine with a focus on hepatology and epidemiology. Their research areas encompass liver disease diagnosis and treatment, liver disease and transplantation, drug-induced hepatotoxicity and protection, as well as associated topics such as alcohol consumption and health effects, liver diseases and immunity, diet, metabolism, and disease, and hepatocellular carcinoma treatment and prognosis.

The scientist has authored numerous publications in prominent journals with frequent appearances in the Journal of Hepatology, Gastroenterology, Hepatology Communications, Hepatology, and The American Journal of Gastroenterology. These venues include 29, 28, 17, 16, and 16 publications respectively.

Among notable research papers authored or co-authored by Naga Chalasani are:

  • Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease, 2021, New England Journal of Medicine
  • Saroglitazar, a PPAR-α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial, 2021, Hepatology
  • ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury, 2021, The American Journal of Gastroenterology
  • High-quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population, 2021, Hepatology
  • A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation, 2022, Nature Genetics

Their frequent co-authors include Marwan Ghabril, Samer Gawrieh, Eric S. Orman, Raj Vuppalanchi, and Archita P. Desai, each having collaborated extensively in over 50 publications with Chalasani.

Chalasani's research deeply engages with subfields such as epidemiology, hepatology, pharmacology, surgery, and pathology and forensic medicine. The range of topics addressed highlights a strong orientation towards clinical and translational aspects of liver diseases and drug-induced liver injury.

The scientist has been recognized as a member of the Association of American Physicians, reflecting a professional affiliation within the medical community.

Best Publications

  • The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

    Naga Chalasani;Zobair Younossi;Joel E. Lavine;Michael Charlton

  • The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

    Naga Chalasani;Zobair Younossi;Joel E. Lavine;Anna Mae Diehl

  • Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

    Arun J. Sanyal;Naga Chalasani;Kris V. Kowdley;Arthur McCullough

  • Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

    Brent A Neuschwander-Tetri;Rohit Loomba;Arun J Sanyal;Joel E Lavine

  • The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

    Naga Chalasani;Zobair Younossi;Joel E. Lavine;Anna Mae Diehl

  • Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents: The TONIC Randomized Controlled Trial

    Joel E. Lavine;Jeffrey B. Schwimmer;Mark L. Van Natta;Jean P. Molleston;Jean P. Molleston

  • Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

    Naga Chalasani;Robert J. Fontana;Herbert L. Bonkovsky;Herbert L. Bonkovsky;Herbert L. Bonkovsky;Paul B. Watkins

  • ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury

    Naga P. Chalasani;Paul Hideyo Hayashi;Herbert L. Bonkovsky;Victor J. Navarro

  • Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study

    Naga Chalasani;Herbert L. Bonkovsky;Robert Fontana;William Lee

  • Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

    Raj Vuppalanchi;Naga Chalasani

  • Endpoints and clinical trial design for nonalcoholic steatohepatitis.

    Arun J. Sanyal;Elizabeth M. Brunt;David E. Kleiner;Kris V. Kowdley

  • Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study

    Eduardo Vilar-Gomez;Eduardo Vilar-Gomez;Luis Calzadilla-Bertot;Vincent Wai-Sun Wong;Marlen Castellanos

  • Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.

    Arun J. Sanyal;Mark L. van Natta;Jeanne Clark;Brent A. Neuschwander-Tetri

  • Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity

    Naga Chalasani;Hisham Aljadhey;Joe Kesterson;Michael D. Murray;Michael D. Murray

  • Drug-Induced Liver Injury Network (DILIN) Prospective Study: Rationale, Design and Conduct

    Robert J. Fontana;Paul B. Watkins;Herbert L. Bonkovsky;Naga Chalasani

  • Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.

    Kris V. Kowdley;Patricia Belt;Laura A. Wilson;Matthew M. Yeh

  • Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers.

    Eduardo Vilar-Gomez;Naga Chalasani

  • Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

    Brent A. Neuschwander-Tetri;Jeanne M. Clark;Nathan M. Bass;Mark L. Van Natta

  • Predictors of inadequate bowel preparation for colonoscopy.

    Reid M Ness;Raj Manam;Helena Hoen;Naga Chalasani

  • Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study

    N. Chalasani;H. L. Bonkovsky;R. Fontana;W. Lee

Frequent Co-Authors

Robert J. Fontana
Robert J. Fontana University of Michigan–Ann Arbor
David E. Kleiner
David E. Kleiner National Institutes of Health
Arun J. Sanyal
Arun J. Sanyal Virginia Commonwealth University
Oscar W. Cummings
Oscar W. Cummings Indiana University
David W. Crabb
David W. Crabb Indiana University
Kris V. Kowdley
Kris V. Kowdley Washington State University
Paul B. Watkins
Paul B. Watkins University of North Carolina at Chapel Hill
Joel E. Lavine
Joel E. Lavine Columbia University
Rohit Loomba
Rohit Loomba University of California, San Diego
Jay H. Hoofnagle
Jay H. Hoofnagle National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a future in medicine opens several alternative degree and career pathways, especially with the flexibility of online learning. For students wanting to work on the administrative side of healthcare, an affordable healthcare administration degree online can be a smart, budget-friendly option. These programs provide foundational knowledge in management, policy, and operations within healthcare systems.

For those motivated to oversee healthcare facilities or lead within the sector, pursuing the cheapest online master degree in healthcare administration can help you reach advanced roles without breaking the bank.

If you are already a registered nurse aiming for the highest clinical positions, the cheapest dnp programs online offer a pathway to leadership and practice-based expertise.

Future pharmacists can also benefit from pharmacy school online accredited programs, allowing you to earn a respected doctorate degree while maintaining flexibility in your schedule.

These online degree options are not only accessible and cost-effective, but also open doors to a wide range of fulfilling healthcare careers beyond the traditional path to medical school.

Best Scientists Citing Naga Chalasani

Trending Scientists

Recently Published Articles